Evaxion A (EVAX) EPS (Weighted Average and Diluted) (2021 - 2023)
Evaxion A (EVAX) reported EPS (Weighted Average and Diluted) of -$12354.3 for Q2 2023, down 16.6% on a YoY basis from -$14813.2 in Q2 2022, and down 16.6% quarter-over-quarter from -$10595.6 in Q2 2022.
Evaxion A (EVAX) EPS (Weighted Average and Diluted) (2021 - 2023) Analysis & Trends
Evaxion A has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at -$12354.3 in Q2 2023.
- For the quarter ending Q2 2023, EPS (Weighted Average and Diluted) fell 16.6% year-over-year to -$12354.3; the trailing twelve-month figure through Jun 2023 stood at -$12354.3 (down 16.6% YoY), and the FY2023 full-year result was -$0.81, up 17.35% from the prior year.
- EPS (Weighted Average and Diluted) for Q2 2023 stood at -$12354.3, down from -$10595.6 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$10595.6 in Q2 2022, with the low at -$23164.0 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$15093.4 across 3 years, with a median of -$12354.3 in 2023.
- The largest YoY upside for EPS (Weighted Average and Diluted) was 8.32% in 2022 against a maximum downside of 30.17% in 2022.
- Evaxion A's EPS (Weighted Average and Diluted) stood at -$11557.6 in 2021, then increased by 8.32% to -$10595.6 in 2022, then retreated by 16.6% to -$12354.3 in 2023.
- The last three EPS (Weighted Average and Diluted) figures came in at -$12354.3 (Q2 2023), -$10595.6 (Q2 2022), and -$23164.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -12,354.35 |
| Jun 30, 2022 | -10,595.56 |
| Mar 31, 2022 | -23,164.00 |
| Jun 30, 2021 | -11,557.63 |
| Mar 31, 2021 | -17,795.65 |